CMPX
Compass Therapeutics, Inc.
$2.33
+0.02 (+0.87%)
At close · Jul 10
Market Cap
$419.60M
Shares
180,087,915
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 8-K | 2026-07-01 | — | |
| 8-K | 2026-06-23 | 2026-06-22 | |
| 8-K | 2026-06-11 | 2026-06-10 | |
| 10-Q | 2026-05-05 | 2026-03-31 | |
| 8-K | 2026-05-05 | — | |
| DEF 14A | 2026-04-29 | 2026-06-10 | |
| 8-K | 2026-04-27 | — | |
| 10-K | 2026-03-05 | 2025-12-31 | |
| 8-K | 2026-03-05 | — | |
| 8-K | 2026-01-06 | — | |
| 8-K | 2025-11-05 | — | |
| 10-Q | 2025-11-05 | 2025-09-30 | |
| 8-K | 2025-08-13 | 2025-08-12 | |
| 10-Q | 2025-08-11 | 2025-06-30 | |
| 8-K | 2025-08-11 | — | |
| 8-K | 2025-06-12 | 2025-06-11 | |
| 8-K | 2025-05-08 | — | |
| 10-Q | 2025-05-08 | 2025-03-31 | |
| DEF 14A | 2025-04-29 | 2025-06-11 | |
| 8-K | 2025-04-01 | — | |
| 10-K | 2025-02-27 | 2024-12-31 | |
| 8-K | 2025-02-27 | — | |
| 8-K | 2025-01-08 | — | |
| 8-K | 2024-12-10 | 2024-12-09 | |
| 10-Q | 2024-11-12 | 2024-09-30 | |
| 8-K | 2024-11-12 | — | |
| 8-K | 2024-08-12 | — | |
| 10-Q | 2024-08-12 | 2024-06-30 | |
| 8-K | 2024-06-17 | 2024-06-13 | |
| 8-K | 2024-05-28 | — | |
| 8-K | 2024-05-13 | — | |
| 10-Q | 2024-05-13 | 2024-03-31 | |
| DEF 14A | 2024-04-29 | 2024-06-13 | |
| 8-K | 2024-04-25 | — | |
| 10-K | 2024-03-21 | 2023-12-31 | |
| 8-K | 2024-03-21 | — | |
| 8-K | 2024-01-09 | 2024-01-08 | |
| 8-K | 2024-01-05 | — | |
| 10-Q | 2023-11-09 | 2023-09-30 | |
| 8-K | 2023-11-09 | — | |
| 8-K | 2023-08-03 | — | |
| 10-Q | 2023-08-03 | 2023-06-30 | |
| 8-K | 2023-06-15 | — | |
| 10-Q | 2023-05-04 | 2023-03-31 | |
| 8-K | 2023-05-04 | — | |
| DEF 14A | 2023-04-27 | 2023-06-15 | |
| 8-K | 2023-04-24 | 2023-04-21 | |
| 10-K | 2023-03-15 | 2022-12-31 | |
| 8-K | 2023-03-10 | — | |
| 8-K | 2023-02-24 | 2023-02-20 |
Showing 1–50 of 88 filings